Viewing Study NCT01271920


Ignite Creation Date: 2025-12-25 @ 4:19 AM
Ignite Modification Date: 2025-12-26 @ 3:20 AM
Study NCT ID: NCT01271920
Status: COMPLETED
Last Update Posted: 2020-12-08
First Post: 2010-11-03
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Combination of AUY922 With Trastuzumab in HER2+ Advanced Breast Cancer Patients Previously Treated With Trastuzumab
Sponsor: Novartis Pharmaceuticals
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module